Clare Sun, MD

Dr. Sun specializes in chronic lymphocytic leukemia (CLL) and other indolent B-cell malignancies. Her areas of interest include drug development, treatment resistance, and host immunity in CLL.

Dr. Sun received a B.Sc. with distinction in Life Sciences from Queen’s University, Canada in 2006 and an M.D. from the University of British Columbia, Canada in 2010. She completed an internal medicine residency at Loyola University Medical Center in 2013 and fellowship in hematology and medical oncology at the National Institutes of Health in 2016. She is currently an Associate Research Physician in the Laboratory of Lymphoid Malignancies and conducts clinical trials in CLL.

Publications

The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia

Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib

BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL

Select Antitumor Cytotoxic CD8+ T Clonotypes Expand in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib

Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines

View More Publications